Clinical Trials Logo

Clinical Trial Summary

This is a 2-year, open-label, randomized study to evaluate the efficacy of Rosuvastatin dosing adjustment by LDL-C level compared to that of 5mg maintenance dose in chinese patients with Carotid Atherosclerosis.


Clinical Trial Description

This will be a 2-year, randomized, open-label, prospective, parallel-group study. It only be held in China-Japan Friendship Hospital. Subjects with Carotid Atherosclerosis Plaques who meet all inclusion and none of the exclusion criteria will be randomized in a 1:1 ratio to receive treatment of rosuvastatin (5 mg, 10mg, 20mg) dosing adjustment by LDL-c level or fixed dose 5 mg. The study will consist of two phases: the Screening/Baseline period(-1to week 0)and the Follow-up period(0 to month 24). The follow-up period will comprise seven visits. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02532309
Study type Interventional
Source China-Japan Friendship Hospital
Contact Cao Fei
Phone 86-10-56259183
Email frank.cao@clinstech-med.com
Status Recruiting
Phase Phase 4
Start date April 2015

See also
  Status Clinical Trial Phase
Completed NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Withdrawn NCT03630835 - 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques Phase 2/Phase 3
Completed NCT02722720 - Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral N/A
Completed NCT01893489 - Visualization of Carotid Atherosclerosis by 68Ga-MSA Phase 1
Withdrawn NCT00861159 - RLIP76 in Human Serum in Adults With Rheumatologic Diseases N/A
Recruiting NCT01743404 - Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis Phase 2
Completed NCT00636766 - Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque N/A
Recruiting NCT06166121 - Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules N/A
Withdrawn NCT03382249 - Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques Phase 1/Phase 2
Recruiting NCT04679727 - The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
Withdrawn NCT02995642 - Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation Phase 2
Suspended NCT01000181 - Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT N/A
Completed NCT00001368 - Potential Risk Factors for Stroke Phase 1
Recruiting NCT04537403 - PET Detection of CCR2 in Human Atherosclerosis Phase 1
Recruiting NCT05800821 - Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning
Completed NCT00147797 - Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy N/A
Completed NCT00147251 - Stop Atherosclerosis in Native Diabetics Study Phase 4
Completed NCT00180518 - ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" Phase 2/Phase 3
Completed NCT05230576 - Intelligent Detection of Carotid Plaque and Its Stability Based on Deep Learning Dynamic Ultrasound Scanning
Terminated NCT03764306 - New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis N/A